Glucagon Kit
Product Images NDC 0378-8067

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glucagon (NDC 0378-8067). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

FDA Label Image

Figure 1 (Image 02)

FDA Label Image

Figure 2 (Image 03)

FDA Label Image

Figure A (Image 04)

Figure A (Image 04)
This is a description of a vial containing powder, a rubber stopper, a flip-off seal, an attached needle, a backstop and plastic clip, a needle protector, and a pre-filled syringe containing diluent with a plunger.*
FDA Label Image

Figure B (Image 05)

FDA Label Image

Figure C (Image 06)

FDA Label Image

Figure D (Image 07)

FDA Label Image

Figure E (Image 08)

FDA Label Image

Box Label (Image 09)

Box Label (Image 09)
This text contains important information about a medication kit that includes a single-dose vial of Glucagon for Injection, USP and a syringe of diluent for Glucagon. The kit is used for subcutaneous, intramuscular, or intravenous administration in adults and pediatric patients over 20 kg. It provides directions on how to mix and administer the medication, as well as storage specifications. The product is manufactured for Mylan Pharmaceuticals Inc. in the USA and made in India. It is important to carefully read the enclosed insert before using the medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.